<Anchor>



Currently, those under the age of 16 are not eligible for the corona vaccine, but in the United States, Pfizer has applied for urgent approval by creating a vaccine that can be shot from 12 to 15 years of age.

Vaccines for younger children are also currently in clinical trials.



This is Kim Jong-won's correspondent from New York.



<Reporter>



Pfizer said that a vaccine clinical trial was conducted on 2,260 adolescents aged 12-15 years old, and that the corona prevention rate was 100%.



Even in the most important aspect of stability, it has been reported that no problems were found.



[Meg Tyrrell/CNBC Medical and Scientific Reporter: Pfizer said that all children who received the vaccine were okay, but if so, there seems to be nothing to worry about.

On the other hand, children in this age group showed stronger immune responses (than adults).] If the



US Food and Drug Administration and the FDA approve urgent use, adolescents aged 12 to 15 will be able to receive the vaccine from the second half of this year.



Pfizer is currently conducting clinical trials for children from 6 months of age to 11 years old, and if approval is granted without any problems, it is expected that all age groups will be able to receive the vaccination as early as next year.



In the case of Johnson & Johnson's Janssen vaccine, on the other hand, some states in the United States have stopped vaccinating the vaccine as there have been cases of side effects such as dizziness and shortness of breath after vaccination.



[Ryan Zuri/North Carolina Public Health Officer: (Regarding the Janssen vaccine), since vaccination was in the early stages, the cause of the side effects has just been analyzed.] The



European Medicines Agency has caused blood clots after

receiving the

Janssen vaccine. It said that there were 4 cases, and that the association is being investigated.



Regarding the controversial AstraZeneca vaccine for blood clots, the World Health Organization recommended vaccination, saying the benefits of the vaccine outweigh the risk of very rare side effects.



(Video coverage: Lee Sang-wook, video editing: Lee Seung-yeol)